medium change;
bradykinin;
prostaglandin E-2;
phospholipase A(2);
tyrosine kinase;
mitogen-activated protein kinase;
D O I:
10.1016/S0014-2999(98)00523-8
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
In Swiss 3T3 fibroblasts, changing the culture medium prior to stimulation resulted in an augmentation of bradykinin-induced prostaglandin E-2 synthesis. The augmentation depended on the duration of the exposure to the fresh medium, with a maximum effect at 1 h. Fetal calf serum in the fresh medium was essential for augmented prostaglandin E-2 synthesis. The medium change slightly augmented the bradykinin-induced increase in intracellular free Ca'+ concentration and phosphoinositide hydrolysis with a different time course from that for prostaglandin E-2 synthesis. 4',5,7-Trihydroxyisoflavone (genistein) and 3,4-dihydroxybenzylidene-malononitrile (tyrphostin 23), inhibitors of tyrosine kinases, and 2'-amino-3'-methoxyflavone (PD98059), an inhibitor of mitogen-activated protein kinase (MAPK) kinase, attenuated the increase in prostaglandin E-2 synthesis. Bradykinin caused phosphorylation of cytosolic phospholipase A(2) and p42/p44 MAPK, which was augmented by the medium change. From the results, it is concluded that activation of MAPK and cycosolic phospholipase A(2) is involved in the augmentation of prostaglandin E-2 synthesis produced by the medium change. (C) 1998 Elsevier Science B.V. All rights reserved.
机构:
Daiichi Pharmaceut Co Ltd, Drug Safety Res Lab, Edogawa Ku, Tokyo 134, JapanDaiichi Pharmaceut Co Ltd, Drug Safety Res Lab, Edogawa Ku, Tokyo 134, Japan
Shimoda, K
Kato, M
论文数: 0引用数: 0
h-index: 0
机构:
Daiichi Pharmaceut Co Ltd, Drug Safety Res Lab, Edogawa Ku, Tokyo 134, JapanDaiichi Pharmaceut Co Ltd, Drug Safety Res Lab, Edogawa Ku, Tokyo 134, Japan